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TCR-mediated induction of IL-2 and IL-2 receptor (IL-2R)
expression are early events in T cell activation requiredT cell activation involves the sustained accumulation
for G1 progression and entry into S phase. Combinato-of T cell receptor (TCR) and IL-2 receptor (IL-2R) medi-
rial signaling via the TCR and IL-2 R downregulatesated signaling events that promote cell cycle entry
the cell cycle inhibitor p27 and activates the cdk4/cdk6and progression. The Ikaros family of nuclear factors
cyclin D and cdk2/cyclin E complexes that promote G1regulate this process by providing thresholds over-
progression and entry into S phase. Although a numbercome by receptor signaling. T cells with reduced levels
of nuclear factors have been identified that control cellof Ikaros activity require fewer TCR engagement
cycle transitions in a variety of cell types (Nourse etevents for activation, exhibit a greater proliferative re-
al., 1994; Elledge, 1996), in quiescent T cells, TCR andsponse to IL-2, and are less sensitive to inhibitors of
coreceptor signaling cascades may target additionalTCR and IL-2R signaling. Upon T cell activation, Ikaros
lymphoid-specific nuclear effectors for entry into theproteins localize in a higher-order chromatin structure
cell cycle. Identifying such lymphoid-restricted cell cy-where they colocalize with components of the DNA
cle regulators is critical in delineating the molecularreplication machinery. Proliferating T cells with reduced
events that underlie stages of T cell differentiation andIkaros activity display chromosome abnormalities. We
function as well as the molecular mechanisms that givepropose that participation of Ikaros in higher-order
rise to a host of lymphoid defects such as lymphopro-chromatin structures controls cell cycle transitions
liferative disorders, autoimmunities and immunodefi-and restricts DNA replication.
ciencies.
The Ikaros gene encodes a family of hemopoietic-
specific transcription factors that are essential for com-Introduction
mitment of early hemopoietic progenitors to the B and
T lymphoid lineages (Georgopoulos et al., 1994; HahmT cell development involves a tightly regulated succes-
et al., 1994; Wang et al., 1996). Lack of Ikaros proteinssion of proliferation and differentiation steps that gener-
in the hemopoietic system causes an early and completeate the appropriate number, type and specificities of
arrest in the production of fetal and postnatal B lympho-functional mature T cells. During thymocyte differentia-
cytes and natural killer cells. T cell differentiation is alsotion, the pre-T cell receptor complex, expressed on dou-
blocked at the fetal stage; however, after birth a smallble negative (CD42/CD82) precursors, mediates their
number of T cell precursors appears in the thymus whichproliferative expansion and differentiation to the double
undergo aberrant differentiation skewed toward the CD4positive stage (CD41/CD81). Signaling via the T cell re-
lineage (Wang et al., 1996). Ikaros also plays a criticalceptor (TCR) complex expressed on late double positive
role in T cell homeostasis. Lack of or a substantial re-(CD41/CD81) thymocytes has a variety of nonprolifera-
duction in the levels of Ikaros DNA-binding activity intive outcomes. High-affinity interactions between T cell
immature thymocytes, as engineered in mice by a nullantigen receptors and self-antigens lead to the apo-
or a dominant-negative mutation in Ikaros, causes theirptotic elimination of double positive cells, whereas en-
clonal expansion and rapid transformation to a neoplas-gagement of receptors with low affinity for self causes
tic state (Winandy et al., 1995; Wang et al., 1996).prolongation of their life span and transition to a mature
Given the dramatic effects that reduction of Ikarosstate (reviewed in Janeway, 1994). Mature naive T cells
has on T cell homeostasis, we tested its role in T cellfollow a similar sequence of proliferation and differentia-
activation. Here we report that, upon T cell activation,tion events, with the cellular outcome of antigenic stimu-
Ikaros proteins enter into a higher-order nuclear struc-lation dependent on the combination of antigen receptor
ture where they colocalize with components of the DNAand coreceptors involved. Engagement of antigen re-
replication machinery. We show that T cells with re-ceptors on mature peripheral T cells can lead to activa-
duced levels of Ikaros activity exhibit facilitated entrytion or anergy, a state that is determined by the number
into the cell cycle in response to TCR and IL-2R engage-of TCRs involved, the duration of their engagement and
ment and are less sensitive to inhibitors of these signal-whether costimulatory or inhibitory receptors are also
ing pathways. Finally, analysis of primary cycling T cells
with reduced Ikaros activity revealed aberrant chromo-* To whom correspondence should be addressed (e-mail: katia_
some structures implicating Ikaros as a regulator ofgeorgopoulos@cbrc.mgh.harvard.edu).
² These authors contributed equally to this work. chromosome propagation.
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Results Ikaros-Mutant T Cells Exhibit Accelerated
Entry into S Phase
The cell cycle distribution of wild-type and Ikaros-Reduction in Ikaros Activity Causes a Reduction
in T Cell Activation Thresholds mutant T cells was examined at different time points
after TCR engagement. For this study, T cells wereGiven the hyperproliferative phenotypes manifested in
vivo among T cells deficient for Ikaros activity (Winandy plated under nonlimiting activation conditions (i.e., at
high cell density and with a high concentration of anti-et al., 1995; Wang et al., 1996), we examined how T cells
with reduced Ikaros activity respond to T cell activation CD3e), and the DNA content was monitored from 24±60
hr (Figure 1C). At 24 hr, the majority (93.8%) of wild-relative to wild-type. For this study, splenic T cells het-
erozygous for either an inactivating (null1/2) or a domi- type T cells had not yet entered S phase and the amount
of DNA synthesis was minimal (Figure 1C). In sharp con-nant-negative (DN1/2) mutation in Ikaros were used.
Based on FACS analyses of thymic and splenic popula- trast, a significant number (17% and 17.8%) of T cells
heterozygous for either of the Ikaros mutations weretions, these do not appear to develop aberrantly, unlike
null2/2 T cells. Ikaros null1/2 T cells display a 50% reduc- in the replicative phase of the cell cycle (Figure 1C).
However, after 36±60 hr of stimulation, a similar propor-tion in Ikaros mRNA (Figure 2A, Ik) and protein (data not
shown) relative to wild-type. In Ikaros DN1/2 T cells, the tion (41.4±51.3%) of wild-type and Ikaros-mutant T cells
were in S phase (Figure 1C).level of Ikaros DNA-binding complexes would be further
reduced since proteins generated by the mutant allelle Reducing Ikaros DNA-binding activity not only facili-
tates the G0 to G1 transition under fewer TCR engage-lack a DNA-binding domain but can dimerize with the
DNA binding isoforms generated by the wild-type allelle ments, it also accelerates the progression from G1 into
S normally mediated by IL-2R signaling (Bierer et al.,and, in principle, interfere with their activity (Sun et al.,
1996). 1990). Memory T cells also display a facilitated entry
into the cell cycle in response to antigenic stimulationT cells were activated with increasing concentrations
of a plate-bound monoclonal antibody against the (Pihlgren et al., 1996). To determine whether T cells with
reduced Ikaros activity have aquired a memory cell phe-CD3e invariant component of the TCR complex and the
amount of DNA synthesis was determined as a measure notype, presumably by undergoing aberrant differentia-
tion, we tested expression of the memory T cell differen-of activation and progression through the cell cycle.
Since the number of TCR molecules per cell was similar tiation markers CD45RA and CD44. No difference in
the percentage of cells expressing these markers wasbetween wild-type and Ikaros-mutant T cells (Figure 1A),
ligand (i.e., antibody concentration) should be propor- detected between wild-type and Ikaros-mutant T cells
(data not shown).tional to signaling in both cell types. However, T cells
with reduced levels of Ikaros activity proliferated better
than wild-type over a range of antibody concentrations Activated Ikaros-Mutant T Cells Hyperrespond
(Figure 1B). In particular, a limiting number of TCR-com- to IL-2
plex engagement events not sufficient to promote signif- Wild-type T cells are more signal-dependent than Ikaros-
icant activation in the wild-type T cell population caused mutant T cells and activate efficiently only at a higher
the robust proliferation of T cells with reduced levels of cell density, where either supporting factors or cell-cell
Ikaros activity (Figure 1B, 0.625 to 20 mg/ml of anti-CD3). interactions suffice to overcome activation thresholds
T cell activation causes the production of cytokines and allow entry into S phase. To determine whether
required to sustain proliferation, such as IL-2 and IL-4. Ikaros-mutant T cells provided more growth- and differ-
Cell density is, therefore, a critical parameter in lympho- entiation-supporting cytokines, the intracellular levels
cyte activation assays, where growth factors serve as of IL-2, IL-4 and IFN-g were examined after activation.
both autocrine and paracrine stimulators of proliferation. Five hours after TCR stimulation, no significant differ-
T cells with reduced levels of Ikaros proliferated at low ence in the intracellular levels of IL-2 or IL-4 or in the
cell densities at which wild-type T cells did not show number of IL-22 (Figure 1D) and IL-42 (data not shown)
any significant response (Figure 1A, 5 3 104±105 cells/ producing cells was detected in Ikaros-mutant relative
well). Moreover, null1/2 and DN1/2 T cells differed in to wild-type T cells. An increase in the number of IFN-
prolifertive responses (Figure 1B, 0.625±2.5 mg/ml of g-producing cells was detected among activated Ikaros-
anti-CD3e at 5 3 104±105 cells/well). At low cell density mutant T cells (Figure 1D). Since IFN-g is not a growth
and under limiting TCR engagement, the proliferative but rather a T cell differentiation factor, it is unlikely to
response of Ikaros DN1/2 T cells was 3- to 6-fold greater account for the difference in T cell proliferation.
than the Ikaros null1/2 T cells, which proliferated 2- to Given that IL-2 is a dominant autocrine growth factor
7-fold better than wild-type T cells (Figure 1B, 0.625±5 in T cell activation (Smith, 1988), the TCR-mediated pro-
mg/ml of anti-CD3e and 5 3 104 cells/well). liferation of Ikaros-mutant and wild-type T cells was
We, therefore, conclude that the number of TCR sig- examined with and without IL-2 added in the culture
naling events required to drive a quiescent T cell into the medium. After 24 hr of TCR stimulation and at low cell
cell cycle depends on the level of Ikaros DNA-binding density, there was a 6-fold difference in DNA synthesis
proteins present in the nucleus. Ikaros DN1/2 T cells are between Ikaros-mutant and wild-type T cells (Figure 1E,
less signal-dependent than Ikaros null1/2 T cells, which 2 3 104 cells). However, when IL-2 was added to the low
in turn are less signal-dependent than wild-type. These density culture (2 3 104 cells), the proliferative difference
data suggest that Ikaros proteins act as a counting between mutant and wild-type T cells increased to 70-
mechanism which monitors TCR signaling events and to 80-fold, with the majority of wild-type cells failing to
proliferate (Figure 1E). At higher cell density (5 3 104controls T cell activation.
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Figure 1. Lower Thresholds of Activation, Accelerated Entry into S, and Hyperresponsiveness to IL-2 in T Cells with Reduced Levels of Ikaros
(A) Wild-type (1/1), Ikaros Null1/2, and Ikaros DN1/2 T cells were stained for expression of TCR.
(B) Wild-type (1/1), Ikaros Null1/2, and DN1/2 splenocytes were activated with decreasing amounts of anti-CD3e antibody. The average
3H-thymidine incorporation was measured after 48 hr of culture. Counts (CPM) due to autoproliferation were for 5 3 104 cells: 720 (1/1), 525
(Null1/2), 950 (DN1/2), for 1 3 105 cells: 1062 (1/1), 730 (Null1/2), and 1917 (DN1/2), for 2 3 105: 2768 (1/1), 2419 (Null1/2), and 6438 (DN1/2).
The same percentage of T cells was present in all three splenocyte populations. Similar results were obtained with purified T cells (data not
shown). The graph shown is representative of three separate experiments. Each point plotted represents the average of triplicate wells, and
the error bars represent the standard deviation.
(C) Purified splenic T cells were cultured in the presence of 20 mg/ml plate-bound anti-CD3e and DNA content was determined by propidium
iodide (PI) staining after 24, 36, and 60 hr. Histograms display PI intensity. Shown below are the percentages of cells in G0/G1, S, or G2/M.
(D) Two-color FACS analysis showing staining of activated wild-type, Ikaros Null1/2 and DN1/2 splenocytes for CD4, CD8 and intracellular
IL-2 and IFN-g. Percentage of positive cells is shown in the upper right quadrant. In parentheses is the percentage of CD4 or CD8 cells in
the culture positive for IL-2 or IFN-g, respectively.
(E) Purified splenic T cells were cultured for 17 hr with 2.5 units/ml of IL-2 and pulsed with 3H-thymidine. 3H-thymidine incorporation was
estimated as the average of triplicate samples.
cells), addition of IL-2 caused only a 3- to 4-fold differ- of cell cycle progression. To maximize the possibility of
ence in proliferation between Ikaros-mutant and wild- observing differences between wild-type and Ikaros-
type T cells (Figure 1E), indicating that, in the presence mutant T cells we used DN1/2 T cells, as they exhibit
of sufficient cell density-dependent signals, both mutant the most pronounced hyperproliferative phenotype. The
and wild-type cells had effectively entered S phase. In cell cycle inhibitor p27 is downregulated at the protein
summary, the TCR-mediated hyperresponsiveness of and mRNA levels to allow G1 progression and entry into
Ikaros-mutant T cells cannot be attributed to an in- S phase (Nourse et al., 1994; Kwon et al., 1997). Protein
creased production of IL-2 but is possibly due to synergy levels of p27 were comparably high in resting and de-
with a hyperactive IL-2R signaling pathway. clined in activated DN1/2 and wild-type T cells (Figure
2B). This downregulation was also observed at the
mRNA level (Figure 2A). In contrast to p27, the cell cycleNormal Expression of Some Signaling and Cell
inhibitors p19 and p21 are upregulated upon T cell acti-Cycle Regulators in Ikaros-Mutant T Cells
vation (Nourse et al., 1994), presumably to regulate theThe facilitated proliferation of Ikaros-mutant T cells in
proliferative response. Protein levels of both of theseresponse to IL-2 implies a deregulation in either IL-2R
inhibitors increased similarly in DN1/2 and wild-type Texpression or in a downstream signaling pathway. In
cells (Figure 2B). Finally, expression of cyclins D, E, Aboth Ikaros-mutant and wild-type T cells, IL-2R was
and cdk2, which promote transition through G1 to S,not expressed in the resting state (Figure 2A), and the
was comparably low in resting cells and similarly upreg-kinetics of induction upon activation were similar (de-
ulated in DN1/2 and wild-type T cells (Figure 2B). Thus,tected at the cell surface 6 hr after activation, data not
the expression of several key factors for T cell cycleshown). Therefore, in Ikaros-mutant T cells, IL-2R ex-
entry and progressionÐIL-2, IL-2R, p27, p21, p19, cdk2pression is not altered, although it is clearly upregulated
and cyclins D, E and AÐis normal in DN1/2 T cells.as they transform to a malignant state (Winandy et al.,
However, it is still possible that expression of some1995).
We next examined expression of several regulators other cell cycle regulator is affected in these cells.
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Figure 2. Expression of Cell Cycle Regula-
tors in Ikaros-Mutant T Cells
(A) Northern blot analysis of IL-2Ra chain,
p27 and Ikaros mRNA levels in resting T cells
versus activated T cells (for 48 hr). The
housekeeping gene GAPDH was used as a
control. Counts in each band are shown be-
low each panel. The first row of numbers
gives the absolute counts (31,000). The sec-
ond row gives a relative value obtained by
dividing the counts of each band by the
counts obtained for GAPDH in the same lane.
Note induction of GAPDH in activated com-
pared to resting T cells. Thus, comparison of
relative expression of Ikaros, IL-2Ra and p27
in resting versus activated cells is not valid.
Ethidium bromide-stained gel displayed in
the lowest panel (EtBr) reveals approximately
equal RNA loading per lane and allows for
comparison of absolute counts in resting ver-
sus activated T cells.
(B) Western blot analysis of extracts from
resting 1/1 and DN1/2 splenocytes (Sp), rest-
ing T cells (0) and T cells activated for 24 hr
(24). Whole cell extracts from 106 cells were
loaded per lane. Antibodies used are shown
on the left. Asterisks indicate dominant-nega-
tive Ikaros isoforms generated by the mutant
locus. ND 5 not done.
Reduced expression of receptors or factors which et al., 1998]) were tested. As observed with PP1, prolifer-
ation of Ikaros-mutant T cells was virtually unaffectednegatively regulate signaling (i.e., CTLA-4 or SHP-1) can
also result in TCR-mediated hyperproliferation (Tivol et by the addition of the Ras inhibitor L739,749, except
for an increase in proliferative capacity at low inhibitoral., 1995; MarengeÁ re et al., 1996; Plas et al., 1996). How-
ever, expression of these negative effectors was found concentrations (Figure 3B). In addition, mutant cells
were less sensitive to the inhibitors of PKC (stauro-to be normal in Ikaros-mutant T cells (data not shown).
sporine) and MEK-1 (PD98059) (Figure 3B). In fact, Ikaros
null1/2 and DN1/2 T cells, showed progressively de-Proliferation of Ikaros-Mutant T Cells Is Less
Sensitive to Signaling Inhibitors creasing sensitivity to PD98059 at concentrations which
had profound effects on the proliferation of wild-type TOne of the earliest events post receptor engagement
is activation of the src-family protein tyrosine kinases cells (Figure 3B, at 50 mM, 20% activity for wild-type
versus 70% null1/2 and 97% activity for DN1/2).(PTKs) fyn and lck (reviewed in Weiss, 1993). Tyrosine
phosphorylation levels in resting and activated T cells A second pathway downstream of the src-PTKs in-
volves phosphatidylinositol 3-kinase (PI 3-kinase) (Fig-were comparable in wild-type and Ikaros-mutants (data
not shown), indicating no major differences in PTK ac- ure 3A). PI 3-kinase can be selectively inhibited by the
pharmacological agent wortmannin (Powis et al., 1994).tivity.
PTKs are selectively inhibited by the pharmacological Ikaros-mutant T cells were dramatically less sensitive
to inhibition of proliferation by wortmannin than wild-agent PP1 (Hanke et al., 1996) (Figure 3A). With increas-
ing concentrations of PP1, wild-type T cells stimulated type T cells. At 100 nm, wild-type T cells showed less
than 10% maximum proliferative capacity, whereaswith anti-CD3e showed a dose-dependent decrease in
proliferative capacity (Figure 3B). In contrast, Ikaros- Ikaros null1/2 and DN1/2 T cells showed 83% and 63%,
respectively (Figure 3B).mutant T cells displayed enhanced proliferation in the
presence of up to 100 ng/ml PP1. However, at a higher A third pathway downstream of the PTKs, which is
inhibited by cyclosporin A, involves phospholipase Cg1concentration (200 ng/ml) of PP1, a decrease in the
proliferative capacity of Ikaros-mutant T cells was also (PLCg1), an increase in intracellular Ca21 and activation
of the protein phosphatase calcineurin (Hanke et al.,observed.
Downstream of the src-PTKs are three major path- 1996) (Figure 3A). At low concentrations (1 ng/ml),
cyclosporin A acted as a potent inhibitor of proliferationways whose signals converge in the nucleus, leading to
changes in gene expression and cell cycle progression for wild-type T cells but had only slight effects on Ikaros-
mutant T cells (Figure 3B). At higher concentrations,(Cantrell, 1996). One includes protein kinase C (PKC),
Ras and the MAP kinase cascade (Figure 3A). Inhibitors however, it was effective in inhibiting the proliferation
of Ikaros-mutant T cells.of proximal and distal components in this pathway were
examined for their effects on the proliferation of Ikaros- Signaling through IL-2R mediates activation of mTOR
and p70 S6 kinase through the MAP kinase pathwaymutant T cells. Staurosporine (PKC inhibitor) (Tamaoki
et al., 1986), L739,749 (farnesylation inhibitor of Ras and is required for the G1 to S transition (Burnett et
al., 1998). Rapamycin is a specific inhibitor of mTOR,[Weiss, 1993]), and PD98059 (MEK-1 inhibitor) [Migone
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Figure 3. T Cells with Reduced Levels of
Ikaros Are Less Sensitive to Signaling Inhib-
itors
(A) Diagram depicts molecular components
of the PKC, PI-3 kinase and calcineurin sig-
naling pathways which lie downstream of
TCR complex and fyn/lck. The PKC pathway
is also operational downstream of IL-2R. The
points of action of inhibitors used in this study
are indicated.
(B) Purified splenic T cells from 1/1, Null1/2,
and DN1/2 mice were plated in the presence
of 20 mg/ml plate-bound anti-CD3e and inhibi-
tors. After 44 hr of culture, cells were pulsed
with 3H-thymidine and the ratio of the average
incorporation per well in the presence versus
absence of inhibitor (3100), is plotted against
inhibitor concentration. Background prolifer-
ation of cells plated in the presence of ham-
ster IgG was similar for all three genotypes.
thus preventing phosphorylation of p70 S6 kinase and protein was detected in a diffuse reticular pattern that
was excluded from nucleoli, as well as in a numberblocking IL-2R signaling (Kuo et al., 1992; Price et al.,
1992; Kwon et al., 1997). Proliferation of Ikaros-mutant of discrete foci (Figure 4A). Upon T cell activation, the
T cells was unaffected by the presence of rapamycin nuclear pattern of Ikaros staining changed markedly to
over a range of concentrations effective in blocking pro- reveal Ikaros protein concentrated in intensely staining
liferation of wild-type T cells. toroidal structures (Figure 4B).
Collectively, these data indicate that when Ikaros lev- To gain insight into how changes in the Ikaros protein
els are reduced, T cells become less sensitive to inhibi- complex correlate with cell cycle transitions, a more
tors of proximal and distal components of the PKC, PI-3 detailed analysis was undertaken. Purified splenic T
kinase and PLCg signaling pathways. This suggests that cells from both wild-type and DN1/2 animals were acti-
the phenotype manifested in Ikaros-mutant T cells is due vated for different lengths of time and pulsed with BrdU
to a molecular defect downstream of these pathways. As prior to harvesting to reveal cells in S phase. Resting
Ikaros activity is reduced, a T cell becomes less signal- wild-type and DN1/2 T cells displayed a similar reticular/
dependent for activation. Ikaros protein may thus serve punctate pattern of Ikaros staining and were negative
as a major nuclear target for the multiple signaling path- for BrdU (Figures 5A and 5B). By 16 hr of activation,
ways downstream of TCR and IL-2R which modulate its most of the wild-type T cells stained negative for BrdU
activity to allow for regulated cell cycle progression. and exhibited a small increase in nuclear size, indicating
they were in G1 (Figure 5A). Small Ikaros toroids were
detected at this stage. By 24 hr of stimulation cells wereChanges in Nuclear Localization of Ikaros
in mid-late G1, as indicated by a 2- to 3-fold increasein Activated T Cells
in nuclear size and lack of BrdU staining. At this stageTaken together, these activation studies suggest that
Ikaros protein was detected in large toroids (Figure 5A).Ikaros activity may change during the T cell cycle. Such
In contrast to wild-type T cells, a significant proportionchanges do not occur at the level of expression, as
of Ikaros DN1/2 T cells stained positive for BrdU byIkaros mRNA decreases slightly and protein levels re-
16 hr, demonstrating their faster progression to S andmain unaffected (Figures 2A and 2B). However, changes
confirming the results shown in Figure 1C.in the nuclear localization of Ikaros protein were de-
tected. In the nuclei of primary resting T cells, Ikaros By 38±44 hr of TCR stimulation wild-type T cells were
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Figure 4. Upon T Cell Activation, Ikaros Is
Incorporated into a Higher-Order Nuclear
Structure
(A) In purified resting T cells, Ikaros protein
is present throughout the nucleus in a diffuse-
reticular pattern of staining and is also con-
centrated in small discrete foci. The ratio of
intensity of Ikaros staining in dots versus dif-
fuse areas is 2±5. Red lines demarcate mea-
surements of staining intensity across the nu-
cleus. Two representative histograms (1 and
2) are shown.
(B) Upon T cell activation Ikaros localizes in
macromolecular toroidal structures. 3D re-
construction of these structures shows that
they are actually cylinders that range from
2±3.5 mM in length and 1.5±2.54 mM in diame-
ter. Two representative intensity histograms
(3 and 4) across the nucleus of an activated
T cell are shown. The y-axis indicates fluores-
cence intensity, the x-axis indicates distance
across the nucleus (in mm). Note that upon T
cell activation the intensity of the diffuse
Ikaros nuclear staining is decreased relative
to the resting state. The same PMT was used
to collect images for resting and activated T
cells and background staining was sub-
tracted prior to image collection.
in S phase, as revealed by positive staining for BrdU required for G1 to S transitions triggered by IL-2R sig-
naling.(Figure 5A), and displayed Ikaros in toroids. The BrdU
staining patterns of these cells indicated that they were
at various stages of S phase, ranging from early (diffuse/ Ikaros Toroids Colocalize with Sites
punctate pattern) to mid (perinuclear) to late (toroids) of DNA Replication
(Nakayasu and Berezney, 1989; O'Keefe et al., 1992). The Ikaros toroids that form in activated T cells are
Irrespective of the stage of S phase, Ikaros protein dis- reminiscent of the staining patterns of DNA replication
played a toroidal pattern. In DN1/2 T cells, Ikaros toroids foci forming at late S (as revealed by BrdU labeling)
were less striking, and a more intense diffuse pattern and of proteins which associate with DNA replication
of staining was observed (Figure 5B). Thus, there is an factories, such as methyltransferase, PCNA, Cyclin A
inverse correlation between the proliferative capacity of and cdk2 (Leonhardt et al., 1992; Cardoso et al., 1993;
Ikaros DN1/2 T cells and the formation of Ikaros toroids, HozaÂ k and Cook, 1994). We, therefore, examined the
suggesting that these higher-order nuclear structures may possibility that Ikaros proteins colocalize with DNA repli-
negatively regulate the G1-S progression. cation foci and factors.
To delineate the signaling events required for the for- In activated wild-type T cells, Ikaros toroids colocal-
mation of Ikaros toroids we used inhibitors of PKC, PI-3, ized with a subpopulation of BrdU-labeled DNA replica-
p70 S6 and tyrosine kinases, which are critical compo- tion clusters (Figures 6A±6C). The staining pattern of the
nents of the TCR and IL-2R signaling pathways. PP1, DNA replication foci with which Ikaros colocalized was
staurosporine and PD98059 (which target TCR signaling indicative of regions of heterochromatin which replicate
pathways) reduced both the number of G1 cells with at the mid-late stages of S phase, such as centromeric
Ikaros toroids and the number of S phase cells (data not heterochromatin and heterochromatin at the interior part
shown). However, rapamycin and wortmannin (which of the nucleus (Nakayasu and Berezney, 1989; O'Keefe
target the IL-2R signaling pathway as inhibitors of the et al., 1992). Ikaros toroids localize in the periphery of
p70 S6 kinase) effectively blocked entry into S yet had heterochromatin, as visualized by Hoechst staining;
a relatively small effect in reducing the number of G1 however, Ikaros ``speckles'' in resting cells are mostly
cells with Ikaros toroids (data not shown). These data excluded from these sites (data not shown). We also
suggest that the formation of Ikaros toroids lies down- tested whether Ikaros colocalized with proteins such
as methyltransferase, which acts on replicating DNA.stream of TCR signaling and occurs prior to the events
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Figure 5. Changes in Nuclear Ikaros Structures in Wild-Type and Dominant-Negative Ikaros-Mutant T Cells upon Activation
Purified splenic T cells from 1/1 mice (A) and from Ikaros DN1/2 mice (B) were activated with 20 mg/ml plate bound anti-CD3e and pulsed
with BrdU for 10 min prior to harvesting at the indicated time points. Cells were stained with antibodies against BrdU (shown in green) to
identify cells in S phase and Ikaros (shown in red). Both resting 1/1 and DN1/2 T cells show a punctate pattern of Ikaros staining over a
diffuse reticular pattern (0 hr). By 24 hr after TCR stimulation, Ikaros is visualized in toroids in of 1/1 T cells and very few cells have incorporated
BrdU, indicating that they are in G1. By 38 hr, the majority of 1/1 T cells are in S phase, and Ikaros is predominantly seen in toroids. In
activated DN1/2 T cells, formation of Ikaros toroids is not seen clearly. Moreover, significant numbers of DN1/2 cells label with BrdU as early
as 16 hr after activation, indicating shortening of G1 phase.
Methyltransferase has been shown to form toroids Chromosomal Aberrations among Cycling
T Cells with Reduced Levels of Ikaroswhich colocalize with replicating heterochromatin in
mid-to-late S phase (Leonhardt et al., 1992). Signifi- Given a potential role for Ikaros in DNA replication and
chromosome propagation, we examined the karyotypescantly, the colocalization of Ikaros and methyltrans-
ferase was 100% (Figures 6D±6F). Colocalization with of cycling wild-type and Ikaros DN1/2, null1/2 and null2/2
T cells. Chromosome spreads of T cells arrested in meta-cyclin A, which associates with DNA replication mega-
complexes, was also detected (Figures 6G±6I). Although phase after 2±3 cell cycles were examined (Figure 7A).
Polyploidy counts on 100 metaphases per genotypeIkaros is detected in the nucleus both in resting T cells
and in G1 through S phase of the cell cycle, it is not showed insignificant differences between Ikaros-mutant
and wild-type T cells, with 2% of wild-type and 1±6%detected on condensed chromosomes during early-mid
M phase. Specifically, Ikaros is not detected in prophase, of Ikaros-mutant metaphases being tetraploid. For each
genotype, exact chromosome counts were also ob-metaphase and anaphase, but it rapidly reappears in a
punctate-reticular pattern in dividing nuclei at telophase tained on 30±40 metaphases. The number of monoso-
mies or trisomies (39 or 41 chromosomes) was signifi-and prior to cytokinesis (Figures 6J and 6K).
Collectively, the colocalization of activation-induced cantly higher among Ikaros-mutant relative to wild-type
T cells (Figure 7B, 5% for wild type, 40% for null1/2,higher-order Ikaros structures with replication-associ-
ated enzymes, like methyltransferase and cyclin A, and 30% for DN1/2 and 17% for null2/2).
Changes in the size of one of the members of chromo-a subset of replication foci suggests a possible role for
Ikaros in DNA replication. some 1 pair were consistently seen in the majority of
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Figure 6. In activated T cells Ikaros colocal-
izes with methyltransferase, Cyclin A and a
subset of DNA replication foci
BrdU-labeled T cells were costained for BrdU
(A), methyltransferase (D) or Cyclin A (G) and
Ikaros (B, E, H).
Superimposition of the two stainings reveals
a number of cells where Ikaros colocalizes
with BrdU and Cyclin A (seen as yellow, C
and I). Colocalization between Ikaros and
methyltransferase (seen as yellow, F) is
100%. The discrete pattern of BrdU foci in
these cells demarcates replication of het-
erochromatic regions which are distributed
from the nuclear periphery to the interior part
of the nucleus and occurs during mid-late
S-phase. DNA staining with 7-aminoactino-
mycin D (7AAD) (shown in red, J) reveals that
Ikaros protein (shown in green, K) is not de-
tected on mitotic chromosomes in meta-
phase and anaphase. However, Ikaros is de-
tected in telophase and in cells undergoing
cytokinesis. An arrow indicates the only cell
in this field which is not undergoing mitosis or
cytokinesis and which has Ikaros in toroidal
structures.
Ikaros-mutant metaphases (Figures 7B and 7C). The The activation of a resting primary T cell is divided
into two steps. The first step is described as the earlymost commonly affected region was between bands
A1-A4 of chromosome 1 (Figure 7B). In addition, extra- G1 ªcompetencyº phase, which requires a critical num-
chromosomal fragments, classified as minutes and usu- ber of TCR-complex engagement events to signal
ally associated with gene amplification events (Sen et changes in the expression of growth factors and recep-
al., 1989), were seen in a number of Ikaros-mutant meta- tors (i.e., IL-2 and IL-2R). The second step, known as
phase spreads (Figure 7D). Changes in band size of ªprogression,º occurs in a growth factor (e.g., IL-2)-
other chromosomes and chromatid breaks were de- dependent fashion and promotes progression through
tected at a lower frequency. a ªrestriction pointº into S phase by inducing changes
Thus, a reduction in Ikaros activity in primary T cells in cell cycle regulators such as cyclins, cyclin dependent
causes the frequent occurrence of chromosome aber- kinases and inhibitors of these kinases (Turner, 1993;
rations. This chromosome infidelity detected in vitro Hunter and Pines, 1994; Nourse et al., 1994; Cantrell,
among proliferating Ikaros-mutant T cells suggests a 1996; Kwon et al., 1997). Changes in these cell cycle
mechanism by which these cells transform to a malig- regulators ultimately affect the activity of the DNA repli-
nant state in vivo in the process of providing immunity cation machinery.
(Winandy et al., 1995). Both steps in T cell activation are deregulated when
Ikaros levels are reduced. In Ikaros-mutant T cells,
ªcompetencyº occurs in response to a reduced numberDiscussion
of TCR signaling events and at low cell density, i.e.,
conditions which are insufficient to promote the G0-G1Our current studies reveal that TCR and IL-2R signaling
transition of T cells with normal levels of Ikaros activity.thresholds which control entry and progression through
Ikaros-mutant T cells hyperrespond to IL-2 and enter Sthe T cell cycle are set by Ikaros proteins. Upon TCR
phase at a faster rate relative to wild-type T cells. Thesesignaling, Ikaros proteins form a higher-order chromatin
effects are not due to an increase in IL-2 production orstructure which we propose serves as a critical regulator
of T cell activation. to significant changes in expression of IL-2R. Several
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Figure 7. Chromosome Aberrations Occur
Rapidly in Cycling Ikaros-Mutant T Cells
(A) Ploidy counts of 1/1 vs Ikaros-mutant T
cells are displayed as the number of polyploid
cells per 100 metaphases (polyploidy), exact
chromosome counts for 30±40 metaphases
(chrom. counts) and the percent aneuploidy.
(B) Representative cytogenetic analysis of
one of four studies carried out with purified
splenic T cells. A close examination of chro-
mosomes was performed on 6±11 meta-
phases with a diploid or aneuploid number
of chromosomes.
(C) Pairs of chromosome 1 from wild-type and
Ikaros-mutant metaphases with a diploid
number of chromosomes. The typical band-
ing pattern of chromosome 1 is shown on the
right. Changes in regions along this chromo-
some are shown with brackets. These result
in a difference in the size of chromosome 1
frequently seen among Ikaros-mutant meta-
phases. Arrows indicate deletions proximal to
the centromere and chromatid breakpoints.
(D) Ikaros-mutant chromosomal spreads fre-
quently show the presence of minute chro-
mosomes (arrows).
key nuclear effectors, cyclin D, E, and A, cdk2, and the findings. These Ikaros structures were shown to be in
close apposition to centromeric heterochromatin (Browncdk inhibitors p27, p19 and p21, which coordinate entry
and progression through the cell cycle, are also unaf- et al., 1997). In addition, our experiments with BrdU-
labeled primary cells demonstrate that the Ikaros to-fected. However, it cannot be ruled out that activity of
some other cell cycle regulator is altered. roids, which form in early-mid G1, are maintained
through S phase and colocalize with a subset of DNALack of Ikaros may affect the signaling network down-
stream of TCR and IL-2R, yet attenuators of TCR signal- replication foci whose staining pattern is indicative of
regions of late-replicating heterochromatin (O'Keefeing, like CTLA-4 and its downstream effector SHP-1, are
expressed normally in Ikaros-mutant T cells. Tyrosine et al., 1992). In this higher-order chromatin structure,
Ikaros shows coincidental staining with methyltransfer-phosphorylation levels in resting and activated T cells
are also similar, indicating that, in the absence of Ikaros, ase and Cyclin A, which associate with and regulate the
DNA replication megacomplex (Leonhardt et al., 1992;signaling pathways are not constitutively active or hy-
perreactive. Unexpectedly, a number of pharmacologi- Cardoso et al., 1993; HozaÂ k and Cook, 1994). Colocaliza-
tion of Ikaros in a chromatin network with DNA replica-cal inhibitors of proximal and distal components of the
PKC, PI-3 kinase and calcineurin signaling cascades are tion foci and enzymes suggests a potential role in DNA
replication which may be to form chromatin boundariesless effective in blocking proliferation of Ikaros-mutant
T cells, suggesting that the defect lies downstream of that regulate DNA accessibility to the transcriptional and
DNA replication machineries (J. Kim, unpublished data;these points. Since signaling through all three pathways
is affected, Ikaros is implicated as a ªmolecular point J. Koipally, unpublished data).
Consistent with this hypothesis, changes in chromo-of convergence.º
The TCR signaling cascades may regulate entry into some bands are detected in primary Ikaros-mutant T cells
after limited in vitro proliferation. An increase in the sizethe T cell cycle by altering the activity of Ikaros proteins.
In support of this hypothesis, TCR signaling modulates of chromosome 1 is consistently seen among the major-
ity of Ikaros mutant metaphases. Changes in the band-the nuclear pattern of Ikaros protein. Inhibitors of TCR
signaling cascades reduce the number of G1 cells with ing pattern of other chromosomes is detected at a lower
frequency. An increase in the size of chromosome bandsIkaros toroids. In quiescent T cells, Ikaros is detected
in a nuclear reticular/punctate pattern mostly not associ- and extrachromosomal fragments frequently seen in
Ikaros-mutant metaphases can result from DNA amplifi-ated with heterochromatin. Upon TCR-mediated T cell
activation, a distinctive network of 8±16 Ikaros toroids cation (Sen et al., 1989). Thus, a reduction of Ikaros
activity facilitates T cell activation and may provide theis discerned which occupies a major part of the nuclear
volume. Reduction in Ikaros toroids, observed in T cells first step towards transformation. Additional defects
caused by unfaithful propagation of genetic materialwith mutations in the Ikaros gene, correlates with lower
TCR signaling thresholds and accelerated entry into S may contribute to the rapid development of T cell neo-
plasias in Ikaros-mutant mice and suggest a novel func-phase. Thus, formation of the Ikaros higher-order chro-
matin structures may be critical for the regulated pro- tion for Ikaros as a tumor suppressor.
Cell division can also influence the state of differentia-gression of a T cell through the cell cycle.
The localization of Ikaros proteins in these ªcup-likeº tion by giving rise to daughter cells which are distinct
from the mother cell. An increasing body of work indi-structures in G1 has been previously reported in B cell
lines (Brown et al., 1997), and is consistent with our cates that maintenance of old or induction of new gene
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Immunofluorescenceprograms in daughter cells is coupled to processes
Purified splenic T cells were prepared and stained as previouslywhich occur either during replication or immediately
described (Wang et al., 1988). To visualize Ikaros and cyclin A, cellsafter (Almouzni and Wolffe, 1993; Brandeis et al., 1993;
were permeabilized for 5 min in PBS/0.5% Triton, fixed for 20 min
Jeppesen, 1997; Araujo et al., 1998). In this light, it is in 4% paraformaldehyde and stained as described. Anti-methyl-
interesting that Ikaros colocalizes with methyltransfer- transferase (anti-pATH52) was a gift of T. Bestor.
ase, which serves to direct replication-coupled DNA
Acknowledgmentsmethylation and may serve to alter gene expression in
the daughter cell, resulting in a more differentiated state.
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